Lates News

date
26/04/2026
Every AI Express News, Open Source Securities released a research report on April 26, giving Aopumai (688293.SH) a "buy" rating. The rating reasons mainly include: 1) the continuous high growth of the cultivation base business, the acquisition of Pengli Biological opens up growth space; 2) the cultivation base business maintains high growth, commercial projects enter a period of rapid growth; 3) CDMO business steadily advances, and the acquisition of Pengli Biology opens up growth space. (Daily Economic News)